| Feedback |  |
Drugs & Medications > gefitinib systemic > User Reviews
User Reviews for gefitinib systemic
Also known as: Iressa
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about gefitinib systemic.
Condition   |
Reviews | Compare | Avg. Ratings |
|
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | 1 review(s) | 21 medications |
 |
9.5 |
Reviews for gefitinib systemic to treat Non-Small Cell Lung Cancer
| Anonymous user said: |  | User Rating: |
|
9.0 |
||
Iressa (gefitinib): My personal experience with Iressa has been very good. The side effects of the drug were so much less than those of intravenous chemotherapy.
When I finished traditional chemotherapy in December 2002 I participated in the clinical trials. I started taking Iressa in January 2003.
My last scan after traditional chemotherapy showed that the cancer was still growing. My next scan, after taking Iressa for 90 days, showed marked improvement in my condition. Each scan thereafter showed slow but detectable improvement.
It is now late May of 2009 and I'm still taking Iressa and still showing signs of improvement. The side effects, while ever-present are far more tolerable than those of traditional chemotherapy.
|
||||||
| May 31, 2009 1:11 PM | ||||||
